FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1892034725> ?p ?o ?g. }

• W1892034725 endingPage "208" @default.
• W1892034725 startingPage "199" @default.
• W1892034725 abstract "Background Despite WHO recommendations to offer pregnant women treatment with praziquantel, many nations continue to withhold treatment, awaiting data from controlled trials addressing safety and efficacy. The objectives of this study were to assess whether treatment of pregnant women with schistosomiasis at 12–16 weeks gestation leads to improved maternal and newborn outcomes and to collect maternal and newborn safety data. Methods This phase 2, randomised, double-blind, placebo-controlled trial was done in 72 baranguays (villages) serviced by six municipal health centres in a schistosomiasis endemic region of northeastern Leyte, Philippines. Pregnant women (at 12–16 weeks gestation) who were otherwise healthy but infected with Schistosoma japonicum were enrolled and randomly assigned (1:1) to receive either over-encapsulated praziquantel (total dose 60 mg/kg given as two split doses) or placebo. Participants, investigators, midwives, and laboratory staff were all masked to treatment. The primary outcome was birthweight. Safety data were collected including immediate reactogenicity, post-dosing toxicology ascertained 24 h after study drug administration, and maternal and newborn serious adverse events. Analysis followed the intention-to-treat principle. Analyses were done using hierarchical generalised linear models to adjust for identified confounders and account for potential clustering of observations within villages and municipalities. This trial is registered with ClinicalTrials.gov, number NCT00486863. Findings Between Aug 13, 2007, and Dec 3, 2012, 370 pregnant women were enrolled and randomly assigned to each treatment group (184 to the placebo group, 186 to the praziquantel group). Most women had low-intensity infections (n=334, 90%). Treatment with praziquantel did not have a significant effect on birthweight (2·85 kg in both groups, β=−0·002 [95% CI −0·088 to 0·083]; p=0·962). Treatment was well tolerated with reactogenicity rates similar to those seen in non-pregnant participants (severe reactions occurred in five patients in the praziquantel group and two in the placebo group, and included headache, fever, and malaise). There were no significant differences in key safety outcomes including abortion, fetal death in utero, and congenital anomalies. Interpretation Results from this study provide important data from a controlled trial in support of the expansion of treatment policies to include pregnant women as recommended by WHO. Funding National Institutes of Health, National Institute of Allergy and Infectious Diseases (U01AI066050)." @default.
• W1892034725 created "2016-06-24" @default.
• W1892034725 creator A5000846665 @default.
• W1892034725 creator A5006500952 @default.
• W1892034725 creator A5008421682 @default.
• W1892034725 creator A5013701702 @default.
• W1892034725 creator A5021640083 @default.
• W1892034725 creator A5026755619 @default.
• W1892034725 creator A5027422706 @default.
• W1892034725 creator A5029001070 @default.
• W1892034725 creator A5043456414 @default.
• W1892034725 creator A5045679113 @default.
• W1892034725 creator A5068934863 @default.
• W1892034725 creator A5073469526 @default.
• W1892034725 creator A5075726840 @default.
• W1892034725 creator A5091411476 @default.
• W1892034725 date "2016-02-01" @default.
• W1892034725 modified "2023-10-13" @default.
• W1892034725 title "Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial" @default.
• W1892034725 cites W101528551 @default.
• W1892034725 cites W1985612680 @default.
• W1892034725 cites W1996978265 @default.
• W1892034725 cites W2008845501 @default.
• W1892034725 cites W2029596018 @default.
• W1892034725 cites W2037482359 @default.
• W1892034725 cites W2047957772 @default.
• W1892034725 cites W2057262290 @default.
• W1892034725 cites W2059833564 @default.
• W1892034725 cites W2070535620 @default.
• W1892034725 cites W2086006653 @default.
• W1892034725 cites W2099965240 @default.
• W1892034725 cites W2100223211 @default.
• W1892034725 cites W2102346370 @default.
• W1892034725 cites W2103475199 @default.
• W1892034725 cites W2123151198 @default.
• W1892034725 cites W2130854972 @default.
• W1892034725 cites W2135847035 @default.
• W1892034725 cites W2147102020 @default.
• W1892034725 cites W2149876461 @default.
• W1892034725 cites W2154166605 @default.
• W1892034725 cites W2164969512 @default.
• W1892034725 cites W2170578976 @default.
• W1892034725 cites W2274533744 @default.
• W1892034725 cites W2287688701 @default.
• W1892034725 cites W2298412257 @default.
• W1892034725 cites W2395799587 @default.
• W1892034725 cites W3122664795 @default.
• W1892034725 cites W4299681602 @default.
• W1892034725 cites W87401161 @default.
• W1892034725 doi "https://doi.org/10.1016/s1473-3099(15)00345-x" @default.
• W1892034725 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4752899" @default.
• W1892034725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26511959" @default.
• W1892034725 hasPublicationYear "2016" @default.
• W1892034725 type Work @default.
• W1892034725 sameAs 1892034725 @default.
• W1892034725 citedByCount "65" @default.
• W1892034725 countsByYear W18920347252016 @default.
• W1892034725 countsByYear W18920347252017 @default.
• W1892034725 countsByYear W18920347252018 @default.
• W1892034725 countsByYear W18920347252019 @default.
• W1892034725 countsByYear W18920347252020 @default.
• W1892034725 countsByYear W18920347252021 @default.
• W1892034725 countsByYear W18920347252022 @default.
• W1892034725 countsByYear W18920347252023 @default.
• W1892034725 crossrefType "journal-article" @default.
• W1892034725 hasAuthorship W1892034725A5000846665 @default.
• W1892034725 hasAuthorship W1892034725A5006500952 @default.
• W1892034725 hasAuthorship W1892034725A5008421682 @default.
• W1892034725 hasAuthorship W1892034725A5013701702 @default.
• W1892034725 hasAuthorship W1892034725A5021640083 @default.
• W1892034725 hasAuthorship W1892034725A5026755619 @default.
• W1892034725 hasAuthorship W1892034725A5027422706 @default.
• W1892034725 hasAuthorship W1892034725A5029001070 @default.
• W1892034725 hasAuthorship W1892034725A5043456414 @default.
• W1892034725 hasAuthorship W1892034725A5045679113 @default.
• W1892034725 hasAuthorship W1892034725A5068934863 @default.
• W1892034725 hasAuthorship W1892034725A5073469526 @default.
• W1892034725 hasAuthorship W1892034725A5075726840 @default.
• W1892034725 hasAuthorship W1892034725A5091411476 @default.
• W1892034725 hasBestOaLocation W18920347252 @default.
• W1892034725 hasConcept C126322002 @default.
• W1892034725 hasConcept C131872663 @default.
• W1892034725 hasConcept C142724271 @default.
• W1892034725 hasConcept C165901193 @default.
• W1892034725 hasConcept C168563851 @default.
• W1892034725 hasConcept C187212893 @default.
• W1892034725 hasConcept C197934379 @default.
• W1892034725 hasConcept C203014093 @default.
• W1892034725 hasConcept C204787440 @default.
• W1892034725 hasConcept C27081682 @default.
• W1892034725 hasConcept C2776225656 @default.
• W1892034725 hasConcept C2777288759 @default.
• W1892034725 hasConcept C2777704310 @default.
• W1892034725 hasConcept C2779234561 @default.
• W1892034725 hasConcept C2779744950 @default.
• W1892034725 hasConcept C2780868878 @default.
• W1892034725 hasConcept C46973012 @default.
• W1892034725 hasConcept C535046627 @default.

• next